- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01678118
Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care
July 21, 2021 updated by: Memorial Sloan Kettering Cancer Center
Patient navigators have been shown to assist people seeking cancer screening and other medical services.
The purpose of this study is to see whether a patient navigator can link smokers to available community resources shown to help smokers quit smoking.
Study Overview
Study Type
Observational
Enrollment (Actual)
16
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States
- Ralph Lauren Center for Cancer Care and Prevention
-
New York, New York, United States, 10031
- Heritage Health Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Participants will also be recruited from Heritage Health Center, located at 1727 Amsterdam Ave, which serves a large proportion to low income, minority patients in Harlem, New York.
Also, from the Ralph Lauren Center for Cancer Care and Cancer Prevention (RLCCCP), a community based Center for the prevention, diagnosis, and treatment of cancer located at 1919 Madison Avenue.
Description
Inclusion Criteria:
- Age ≥ 18 years
- Self-reported current daily smoker, as verified with a portable alveolar carbon monoxide (CO) analyzer (24 hour point prevalence); CO levels ≥ 8 ppm.
- English and/or Spanish-speaking
- Referred to the navigation program by their primary care clinician
- At baseline, participants report at least thinking about quitting (i.e., Contemplation or Preparation stages of readiness to quit).
Exclusion Criteria:
- Serious, untreated psychiatric illness (e.g., schizophrenia,) or active substance abuse likely to preclude adherence to the protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
minority smokers
A single arm ABA design will be used to pilot a tobacco-focused patient navigation (TPN) intervention for low income, minority smokers.
|
The pt navigator will phone (email, text, or other preferred method of contact) pts prior to the date of previously set individual goals (e.g.
going to an appt, getting their cessation medications filled, etc) as a reminder & to discuss barriers such as finances, transportation or ambivalent motivation.
In this manner, pts receive navigation services tailored to their individual needs & barriers.
Once pts are connected with a cessation service (defined as either using cessation medication or at least 1 contact with a Quitline or community-based cessation counselor)or provider-prescribed cessation medication usage, continues the navigation intervention will be considered complete.
W/I the 3 month engagement period, pts will receive up to 6 contacts from the Pt Navigator following referral from primary care provider.
Consistent with recommended pt navigation practice, the navigator will provide feedback to primary care provider regarding cessation services that the pts are receiving.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
patient navigation (TPN) feasibility
Time Frame: 1 year
|
To evaluate the study's potential in terms of its reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) of the intervention, tobacco-dependent patients will be asked to complete an intake interview and a telephone follow-up interview (at 3 to 6 months post-intervention).
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2011
Primary Completion (Actual)
July 20, 2021
Study Completion (Actual)
July 20, 2021
Study Registration Dates
First Submitted
August 30, 2012
First Submitted That Met QC Criteria
August 31, 2012
First Posted (Estimate)
September 3, 2012
Study Record Updates
Last Update Posted (Actual)
July 27, 2021
Last Update Submitted That Met QC Criteria
July 21, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Other Study ID Numbers
- 11-028 (ROCTR)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Minority Smokers
-
Philip Morris Products S.A.CompletedSmokers | Never SmokersUnited States
-
University of CoimbraActive, not recruitingMinority StressPortugal
-
Universitätsmedizin MannheimCompletedHealthy Subjects | Non-smokers | Smokers
-
Yale UniversityNational Institute of Mental Health (NIMH)CompletedSexual Minority StressUnited States
-
Kaohsiung Veterans General Hospital.CompletedCurrent Smokers | Past Smokers | Never SmokersTaiwan
-
Helsinn Healthcare SACelerionCompletedHealthy Volunteers | Non-smokers | Moderate to Heavy SmokersUnited States
-
University of Alabama at BirminghamRecruiting
-
MTI UniversityCompleted
-
IRCCS San RaffaeleCompleted
Clinical Trials on Patient Navigator
-
Boston Medical CenterActive, not recruiting
-
Baystate Medical CenterCompleted
-
Medical University of South CarolinaNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaboratorsCompleted
-
McGill University Health Centre/Research Institute...The Hospital for Sick Children; Canadian Institutes of Health Research (CIHR); Unity Health TorontoRecruitingPatient NavigationCanada
-
Case Comprehensive Cancer CenterCompletedPositive FIT or Stool DNA Testing Follow upUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); University of Ottawa; Ontario... and other collaboratorsCompletedHealth Care Inequity, Patient NavigationCanada
-
University of AlbertaRecruitingChronic Diseases in AdolescenceCanada
-
University of CalgaryAlberta Health services; University of AlbertaCompletedStroke | Epilepsy | Autoimmune Diseases | Endocrine System Diseases | Diabetes | Hematologic Diseases | Genetic Diseases, Inborn | Traumatic Brain Injury | Autism Spectrum Disorder | Respiratory Disease | Cardiac Disease | Metabolic Disease | Renal Disease | Neuro-Degenerative Disease | Fetal Alcohol Spectrum Disorders | Gastro-Intestinal DisorderCanada
-
Alison GalbraithHarvard School of Public Health (HSPH); Agency for Healthcare Research and... and other collaboratorsCompletedChronic Obstructive Pulmonary Disease | Hospital Readmission | Congestive Heart Failure | Post-discharge Care TransitionsUnited States
-
University of California, RiversideNot yet recruiting